In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Amdepin; Amlodin; Amlogard; Amlopin; Amlor; Caduet (Pfizer); Exforge (Novartis); Istin (Pfizer); Lotrel (Novartis); Norvas; Norvasc (Pfizer); Prestalia (Symplmed); Tekamlo (Novartis)
- INDICATIONS: Hypertension, angina
- CLASS: Antiarrhythmic class IV, Calcium channel blocker
- HALF-LIFE: 30–50 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Carbamazepine, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Conivaptan, Delavirdine, Epirubicin, Imatinib, Phenytoin, Primidone, Sildenafil, Simvastatin, St John's Wort, Tadalafil, Telaprevir
- See adverse reactions attributed to class:
Caduet is amlodipine and atorvastatin; Exforge is amlodipine and valsartan; Lotrel is amlodipine and benazepril; Prestalia is amlodipine and perindopril; Tekamlo is amlodipine and aliskiren.
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of amlodipine with perindopril in the Informa Healthcare journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 09/22/2024
